Deanne Dilley

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies

Emma Guttman‐Yassky, Jacob P. Thyssen, Jonathan I. Silverberg et al. · Journal of Allergy and Clinical Immunology · 2022 · 63 citations · Full text

Medicine, Dermatology, Pharmacology +14

Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme

Roy Fleischmann, Jeffrey R. Curtis, Christina Charles‐Schoeman et al. · Annals of the Rheumatic Diseases · 2023 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide‐naive patients with partial‐onset seizures

Nathan B. Fountain, Gregory L. Krauss, Jouko Isojärvi et al. · Epilepsia · 2012 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Edwin Liu, Deanne Dilley, Belinda McDonough et al. · Pediatric Drugs · 2019 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine

Kimford J. Meador, David W. Loring, Alan Boyd et al. · Epilepsy & Behavior · 2016 · 33 citations

Medicine, Neurology, Pharmacology +11